image by: HWN

HWN Suggests

My Tirzepatide Journey: A Personal Story

Starting tirzepatide was a mixed bag. The injections were easy enough, but the nausea… that was rough. Especially after the first dose increase. It was a wave of queasiness that made it hard to eat. I learned quickly that smaller, more frequent meals were key. Bland foods like crackers and broth became my best friends. My appetite changed drastically. The constant hunger pangs I was so used to started to fade. It was strange, but also liberating. I had to learn to listen to my body’s new signals, which were much quieter.

read full article

Featured

 Cheaper Version of Tirzepatide for Weight Loss Now Available, Lilly Says

The manufacturer is selling single-dose vials of the drug via its online pharmacy at around $400 to $500 for a 4-week supply.

Articles of Interest

Adverse Events Related to Tirzepatide

Tirzepatide is associated with a dose-dependent increase in incidence of GI AEs and AEs leading to drug discontinuation. Severe hypoglycemia, fatal AEs, acute pancreatitis, cholelithiasis, and cholecystitis are rare with this medication.

Diabetes drug leads to notable weight loss in people with obesity – study

Experts say the apparent effects of a weekly dose of tirzepatide are potentially game changing.

I Tried Tirzepatide. Here’s what happened.

My perimenopause journey is not unlike the next woman. I feel like I was doing everything “right” by my body. I was eating well, moving often, prioritizing protein (can we really ever eat enough?!), walking, lifting weights, running lab tests, doing functional medicine protocols and even removed my breast implants. I was on a transdermal estradiol patch and nightly micronised progesterone. Still, my body felt like it was in a state of teenage rebellion. Which I know well, with teenagers under our roof

Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP

Dave Ricks is pushing his scientists to find an even more potent anti-obesity treatment. ‘Lilly’s got a lead, and we plan to exploit that lead.’

My 7-Month Journey on Tirzepatide (Zepbound)

When people ask how I lost 70 pounds in seven months, I tell them the truth: I had help. Not from a trainer or a miracle diet (although, those probably wouldn't have hurt), but from a weekly injection called Tirzepatide, known by its brand name Zepbound. It wasn't magic. It was science, discipline, and a big dose of self-awareness. Between December and July, I went from 334 pounds down to 259. Here's exactly how it happened, what it felt like, and what I'd tell anyone thinking about trying it

New drug tirzepatide delivers significant and long-lasting weight loss

Tirzepatide treatment results in sustained weight loss for three years in adults without diabetes, reveals major obesity study. Tirzepatide mimics two key hormones in your body, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Both hormones play essential roles after eating, signaling your pancreas to release insulin. Tirzepatide also slows the stomach's digestion rate and communicates with the brain to create a sense of fullness, reducing hunger significantly.

Not losing weight on tirzepatide? Here’s what to do about it

Don't worry—you don't need to transform your entire diet overnight. Start with small changes that fit your life, like swapping fried chicken for grilled, choosing water instead of soda with meals, or adding an extra serving of vegetables to your plate. Even something as simple as having a small salad before your favorite pizza can make a difference.

Real-World Safety Concerns of Tirzepatide: A Retrospective Analysis of FAERS Data (2022–2025)

Tirzepatide (Mounjaro or Zepbound), a dual GLP-1/GIP receptor agonist, is approved for type 2 diabetes and weight management. Despite its efficacy, real-world safety data remain limited. This study analyzed post-marketing adverse events (AEs) associated with tirzepatide using the FDA Adverse Event Reporting System (FAERS) to identify emerging safety concerns.

The Hidden Risks of "Gray Market" Tirzepatide: Why Purity Matters for Your Long-Term Health

The surge in popularity of GLP-1 medications for weight loss has led to a dangerous "gray market" of unregulated products... While the lower price point is tempting, the long-term health consequences of using these unapproved substances can be severe and, in some cases, irreversible.

Tirzepatide Bests Semaglutide in Relative, Average Weight Loss in Obesity, Overweight

Topline results from the SURMOUNT-5 clinical trial announced today show that tirzepatide (Zepbound) use was associated with a 47% greater relative weight loss vs semaglutide (Wegovy), according to a news release from tirzepatide manufacturer Eli Lilly.

Tirzepatide Tips and Tricks: Expert Strategies for Optimal Results

Maximizing therapeutic outcomes requires more than just administering the medication—proper injection technique, strategic side effect management, lifestyle integration, and correct storage practices are essential for treatment success.

Tirzepatide, for treatment of adults with obesity, is on the fast track for FDA's OK

There are signs that obesity drugs are improving. A new drug being "fast-tracked" for FDA approval has been shown to help users lose more than a fifth of their body weight.

Tirzepatide, Worth the Weight?

Tirzepatide (Mounjaro) is the first in its class peptide that activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Both GIP and GLP-1 are incretin hormones released in response to nutrient uptake in the gut, however GIP is responsible for ~2/3 of the total effect, allowing a synergistic effect with tirzepatide’s mechanism. Similar to other GLP-1, GIP stimulates insulin secretion in hyperglycemic states. However, unlike GLP-1, GIP only suppresses glucagon secretion in hyperglycemic states, leading to potentially lower risk of hypoglycemia.

Tirzepatide: Your New BFF in Beating Emotional Eating

One of tirzepatide’s main benefits is its ability to reduce appetite. By stimulating GLP-1 and GIP receptors, it sends signals to your brain that you’re full, even with smaller portions. This means that even when emotional eating might take over, you may not feel as compelled to reach for high-calorie comfort foods. As a result, maintaining a calorie deficit becomes easier.

Why Isn’t There Oral Tirzepatide? What To Know About Tirzepatide And Which Oral GLP-1s Are Approved For Weight Loss

At the time of this writing, there does not appear to be an oral tirzepatide product in clinical trials. In a statement to Fierce Healthcare in a February report on a lawsuit involving companies selling compounded oral tirzepatide products, Eli Lilly, which makes FDA-approved tirzepatide drugs, said: “There are no human studies—let alone clinical trials—involving any oral tirzepatide product, meaning anyone selling oral tirzepatide is making unproven claims and experimenting on unsuspecting Americans.”

Why Tirzepatide is Your Best Weight Loss Ally

Losing weight can be a challenging and emotional experience. For many, traditional approaches such as diet and exercise may not provide the desired results. However, advancements in medical science have introduced new and effective solutions for weight loss. Tirzepatide is one such groundbreaking option that is transforming the way people lose weight. Not only is it backed by science, but it also offers significant results that could make a difference in your life.

Resources

StatPearls

Tirzepatide is currently utilized as a second-line diabetes medication akin to GLP-1 drugs, such as semaglutide, and is administered once weekly via subcutaneous injection with incremental dosage adjustments. Tirzepatide is not approved for the treatment of type 1 diabetes mellitus (T1DM) and has not undergone studies in patients with pancreatitis. The most commonly reported adverse effects of the drug are gastrointestinal, including nausea, vomiting, and diarrhea.